An AbbVie arthritis drug, upadacitinib, sold as Rinvoq, restored substantial scalp coverage in 55% of severe alopecia areata patients within…
Read More

An AbbVie arthritis drug, upadacitinib, sold as Rinvoq, restored substantial scalp coverage in 55% of severe alopecia areata patients within…
Read More